FindTrial
Sign In

Retrospective study on endoscopic ultrasonographic aspiration histology for malignant lymphoma

Retrospective study on endoscopic ultrasonographic aspiration histology for malignant lymphoma - EUS-FNAB for malignant lymphoma

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000049025
Enrollment
50
Registered
2022-09-27
Start date
2022-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Lymphoma

Interventions

None listed

Sponsors

Shimane University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Diagnosed with malignant lymphoma by pathological examination between April 2012 and July 2022. 2) Between April 2012 and July 2022, endoscopic ultrasonography-guided fine-needle aspiration histology was performed on the lymph nodes, and we have requested histological examination.

Exclusion criteria

Exclusion criteria: 1) Advanced cancer in other organs 2) Viral disease causing lymphadenopathy such as infectious mononucleosis 3) Sarcoidosis, autoimmune diseases, etc.

Design outcomes

Primary

MeasureTime frame
Lesion size, type diagnosis of malignant lymphoma, Logistic regression analysis will be performed to determine whether the thickness of the puncture needle, the type of puncture needle, the length of the stroke, the number of sessions at the time of puncture, and the scope position at the time of puncture are the success factors of EUS-FNAB as independent variables.—

Countries

Japan

Contacts

Public ContactNobuhiko Fukuba

Shimane University Gastroenterology

fnat98@yahoo.co.jp0853-20-2190

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026